• Explore /
  • Poster
  • / Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.

Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.

Abstract Poster

Authors

Toni Choueiri

Toni K. Choueiri

Dana-Farber Cancer Institute, Boston, MA

Toni K. Choueiri , David J Figueroa , Yuan Liu , Robert C. Gagnon , Keith C. Deen , Christopher Carpenter , Arundathy N. Bartlett-Pandite , Paul De Souza , Tom Powles , Robert John Motzer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 416)

DOI

10.1200/jco.2014.32.4_suppl.416

Abstract #

416

Poster Bd #

B18

Abstract Disclosures

Similar Posters

First Author: Monique Celeste Tavares

First Author: Melissa Lynne Johnson

First Author: Mathilde Cancel

First Author: Farshid Dayyani